Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	MISP CCDC8 AKAP9 CEP250 CGN NUMA1 DNAH2 CEP131 CEP152 PCNT	1.06e-05	720	52	10	GO:0000226
GeneOntologyBiologicalProcess	microtubule-based process	MISP CCDC8 AKAP9 CEP250 CGN NUMA1 DNAH2 CEP131 CEP152 KIF7 PCNT	5.34e-05	1058	52	11	GO:0007017
GeneOntologyBiologicalProcess	centrosome localization	MISP AKAP9 SYNE1	9.34e-05	35	52	3	GO:0051642
GeneOntologyBiologicalProcess	microtubule organizing center localization	MISP AKAP9 SYNE1	1.02e-04	36	52	3	GO:0061842
GeneOntologyBiologicalProcess	organelle assembly	MISP DCDC2 SYNE1 CEP250 NUMA1 DNAH2 ABCB6 CEP131 CEP152 WNK3 PCNT	1.03e-04	1138	52	11	GO:0070925
GeneOntologyBiologicalProcess	calcium ion import	CACNB2 SLC24A2 ACE WNK3	1.09e-04	98	52	4	GO:0070509
GeneOntologyBiologicalProcess	protein localization to microtubule organizing center	CEP250 NUMA1 CEP131	1.30e-04	39	52	3	GO:1905508
GeneOntologyBiologicalProcess	regulation of heart rate by cardiac conduction	CACNB2 AKAP9 ACE	1.51e-04	41	52	3	GO:0086091
GeneOntologyBiologicalProcess	regulation of protein localization to cell cortex	MISP NUMA1	2.22e-04	9	52	2	GO:1904776
GeneOntologyCellularComponent	microtubule organizing center	MISP DCDC2 CCDC8 AKAP9 CEP95 CEP250 NUMA1 CCDC18 CEP131 CEP152 KIF7 PCNT	1.58e-06	919	51	12	GO:0005815
GeneOntologyCellularComponent	centrosome	MISP DCDC2 CCDC8 AKAP9 CEP95 CEP250 NUMA1 CCDC18 CEP131 CEP152 PCNT	1.95e-06	770	51	11	GO:0005813
GeneOntologyCellularComponent	spindle pole centrosome	MISP CEP250 NUMA1	1.29e-05	19	51	3	GO:0031616
GeneOntologyCellularComponent	pericentriolar material	AKAP9 CEP152 PCNT	4.29e-05	28	51	3	GO:0000242
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	NES MISP DCDC2 NUMA1 DNAH2 BYSL BFSP2 PPL KIF7 PCNT	5.28e-05	899	51	10	GO:0099513
GeneOntologyCellularComponent	3M complex	CCDC8 ANKRA2	5.81e-05	5	51	2	GO:1990393
GeneOntologyCellularComponent	supramolecular fiber	NES MISP DCDC2 SYNE1 NUMA1 DNAH2 BYSL BFSP2 PPL KIF7 PCNT	1.04e-04	1179	51	11	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	NES MISP DCDC2 SYNE1 NUMA1 DNAH2 BYSL BFSP2 PPL KIF7 PCNT	1.10e-04	1187	51	11	GO:0099081
GeneOntologyCellularComponent	ciliary basal body	AKAP9 CEP250 CEP131 KIF7 PCNT	1.11e-04	195	51	5	GO:0036064
GeneOntologyCellularComponent	mitotic spindle astral microtubule	MISP NUMA1	1.62e-04	8	51	2	GO:0061673
GeneOntologyCellularComponent	centriolar satellite	DCDC2 CCDC18 CEP131 PCNT	2.68e-04	128	51	4	GO:0034451
GeneOntologyCellularComponent	microtubule	MISP DCDC2 NUMA1 DNAH2 BYSL KIF7 PCNT	2.95e-04	533	51	7	GO:0005874
GeneOntologyCellularComponent	astral microtubule	MISP NUMA1	3.16e-04	11	51	2	GO:0000235
GeneOntologyCellularComponent	aster	MISP NUMA1	3.79e-04	12	51	2	GO:0005818
GeneOntologyCellularComponent	low-density lipoprotein particle	PLA2G7 APOBR	6.85e-04	16	51	2	GO:0034362
GeneOntologyCellularComponent	centriole	CEP250 CEP131 CEP152 PCNT	8.18e-04	172	51	4	GO:0005814
GeneOntologyCellularComponent	cilium	DCDC2 AKAP9 CEP250 DNAH2 CEP131 ACE KIF7 PCNT	1.39e-03	898	51	8	GO:0005929
GeneOntologyCellularComponent	spindle pole	MISP CEP95 CEP250 NUMA1	1.57e-03	205	51	4	GO:0000922
Domain	PACT_domain	AKAP9 PCNT	7.60e-06	2	52	2	IPR019528
Domain	PACT_coil_coil	AKAP9 PCNT	7.60e-06	2	52	2	PF10495
Domain	G-protein_beta_WD-40_rep	TBL3 FBXW7 WDR48	1.71e-03	85	52	3	IPR020472
Domain	Spectrin_repeat	SYNE1 PPL	2.94e-03	29	52	2	IPR002017
Domain	Spectrin/alpha-actinin	SYNE1 PPL	3.57e-03	32	52	2	IPR018159
Domain	SPEC	SYNE1 PPL	3.57e-03	32	52	2	SM00150
Pathway	REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES	AKAP9 CEP250 NUMA1 CEP131 CEP152 PCNT	2.18e-07	95	39	6	M6729
Pathway	REACTOME_AURKA_ACTIVATION_BY_TPX2	AKAP9 CEP250 CEP131 CEP152 PCNT	1.52e-06	72	39	5	M27749
Pathway	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES	AKAP9 CEP250 CEP131 CEP152 PCNT	2.73e-06	81	39	5	M748
Pathway	REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION	AKAP9 CEP250 CEP131 CEP152 PCNT	3.89e-06	87	39	5	M27194
Pathway	REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES	AKAP9 CEP250 NUMA1 CEP131 CEP152	4.60e-06	90	39	5	MM14979
Pathway	REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE	AKAP9 CEP250 CEP131 CEP152 PCNT	6.65e-06	97	39	5	M27478
Pathway	REACTOME_MITOTIC_PROMETAPHASE	AKAP9 CEP250 NUMA1 CEP131 CEP152 PCNT	1.87e-05	204	39	6	M4217
Pathway	REACTOME_AURKA_ACTIVATION_BY_TPX2	AKAP9 CEP250 CEP131 CEP152	4.25e-05	71	39	4	MM15495
Pathway	REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION	AKAP9 CEP250 CEP131 CEP152	8.62e-05	85	39	4	MM14906
Pathway	REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE	AKAP9 CEP250 CEP131 CEP152	1.38e-04	96	39	4	MM15207
Pathway	REACTOME_MITOTIC_G2_G2_M_PHASES	AKAP9 CEP250 CEP131 CEP152 PCNT	2.13e-04	200	39	5	M864
Pathway	REACTOME_CILIUM_ASSEMBLY	AKAP9 CEP250 CEP131 CEP152 PCNT	2.18e-04	201	39	5	M27472
Pathway	REACTOME_MITOTIC_PROMETAPHASE	AKAP9 CEP250 NUMA1 CEP131 CEP152	2.23e-04	202	39	5	MM15362
Pathway	BIOCARTA_AKAPCENTROSOME_PATHWAY	AKAP9 PCNT	4.84e-04	12	39	2	MM1460
Pathway	REACTOME_CELL_CYCLE	AKAP9 SYNE1 CEP250 POLR2D NUMA1 CEP131 CEP152 PCNT	5.24e-04	694	39	8	M543
Pathway	BIOCARTA_AKAPCENTROSOME_PATHWAY	AKAP9 PCNT	6.65e-04	14	39	2	M15347
Pathway	REACTOME_PHASE_2_PLATEAU_PHASE	CACNB2 AKAP9	6.65e-04	14	39	2	MM15198
Pathway	REACTOME_PHASE_2_PLATEAU_PHASE	CACNB2 AKAP9	7.65e-04	15	39	2	M27456
Pathway	REACTOME_M_PHASE	AKAP9 CEP250 NUMA1 CEP131 CEP152 PCNT	9.21e-04	417	39	6	M27662
Pathway	REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE	AKAP9 CEP250 CEP131 CEP152 PCNT	1.28e-03	297	39	5	M27050
Pathway	REACTOME_MITOTIC_G2_G2_M_PHASES	AKAP9 CEP250 CEP131 CEP152	1.62e-03	184	39	4	MM15145
Pubmed	Novel asymmetrically localizing components of human centrosomes identified by complementary proteomics methods.	AKAP9 CEP95 CEP250 CEP131 CEP152 PCNT	1.08e-07	146	54	6	21399614
Pubmed	Proximity interactions among centrosome components identify regulators of centriole duplication.	CEP250 CEP131 CEP152 KIF7 PCNT	5.28e-07	101	54	5	24613305
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NES CCDC8 AKAP9 CEP95 CGN CCDC18 CEP131 CEP152 ZNF598 WNK3	7.33e-07	861	54	10	36931259
Pubmed	The centrosomal protein C-Nap1 is required for cell cycle-regulated centrosome cohesion.	AKAP9 CEP250 CEP131 PCNT	1.80e-06	56	54	4	11076968
Pubmed	The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation.	AKAP9 CEP250 CEP131 PCNT	1.93e-06	57	54	4	16462731
Pubmed	Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation.	AKAP9 CEP250 CEP131 PCNT	2.07e-06	58	54	4	12852856
Pubmed	Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function.	AKAP9 CEP250 CEP131 PCNT	2.54e-06	61	54	4	7790358
Pubmed	Transcriptomic analysis and novel insights into lens fibre cell differentiation regulated by Gata3.	PLA2G7 DCDC2 BFSP2	3.37e-06	19	54	3	31847788
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	NES CCDC8 SYNE1 CGN NUMA1 CEP131 SRCAP TBL3 KIF7 PCNT	3.46e-06	1024	54	10	24711643
Pubmed	Centrosomal proteins CG-NAP and kendrin provide microtubule nucleation sites by anchoring gamma-tubulin ring complex.	AKAP9 CEP250 CEP131 PCNT	3.48e-06	66	54	4	12221128
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CCDC8 AKAP9 POLR2D CGN CCDC18 CEP131 KIF7 PCNT FBXW7 WDR48	4.28e-06	1049	54	10	27880917
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	GRIPAP1 CEP95 CEP250 CGN CEP152 ZNF598 ACE KIF7 PCNT	6.09e-06	853	54	9	28718761
Pubmed	Killer-cell immunoglobulin-like receptors and falciparum malaria in southwest Nigeria.	KIR2DS3 KIR2DS5	7.09e-06	3	54	2	24929143
Pubmed	Activated ezrin controls MISP levels to ensure correct NuMA polarization and spindle orientation.	MISP NUMA1	7.09e-06	3	54	2	29669740
Pubmed	Apolipoprotein E, angiotensin-converting enzyme and alpha-1-antichymotrypsin genotypes are not associated with post-stroke dementia.	SERPINA3 ACE	7.09e-06	3	54	2	12736093
Pubmed	A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation.	KIR2DS3 KIR2DS5	7.09e-06	3	54	2	8765026
Pubmed	Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.	KIR2DS3 KIR2DS5	7.09e-06	3	54	2	19500138
Pubmed	Hook3 interacts with PCM1 to regulate pericentriolar material assembly and the timing of neurogenesis.	NES PCNT	1.42e-05	4	54	2	20152126
Pubmed	Analysis of candidate genes and hypertension in African American adults.	SERPINA3 ACE	1.42e-05	4	54	2	19341158
Pubmed	Nesprin-1α-Dependent Microtubule Nucleation from the Nuclear Envelope via Akap450 Is Necessary for Nuclear Positioning in Muscle Cells.	AKAP9 SYNE1	1.42e-05	4	54	2	28966089
Pubmed	Neuroepithelial stem cell proliferation requires LIS1 for precise spindle orientation and symmetric division.	NES PCNT	1.42e-05	4	54	2	18267077
Pubmed	A role for KIR gene variants other than KIR2DS1 in conferring susceptibility to psoriasis.	KIR2DS3 KIR2DS5	1.42e-05	4	54	2	16829306
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NES CACNB2 AKAP9 SYNE1 NUMA1 CEP131 WNK3 KIF7 PCNT	1.60e-05	963	54	9	28671696
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	NES GRIPAP1 CGN NUMA1 PPL PCNT	2.00e-05	360	54	6	33111431
Pubmed	In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans.	KIR2DS3 KIR2DS5	2.36e-05	5	54	2	19410616
Pubmed	MDM1 is a microtubule-binding protein that negatively regulates centriole duplication.	CEP250 CEP152	2.36e-05	5	54	2	26337392
Pubmed	Cdk5rap2 interacts with pericentrin to maintain the neural progenitor pool in the developing neocortex.	NES PCNT	2.36e-05	5	54	2	20471352
Pubmed	The centriolar satellite protein Cep131 is important for genome stability.	CEP131 PCNT	2.36e-05	5	54	2	22797915
Pubmed	CENP-32 is required to maintain centrosomal dominance in bipolar spindle assembly.	AKAP9 NUMA1	2.36e-05	5	54	2	25657325
Pubmed	Periplakin interactions with lens intermediate and beaded filaments.	BFSP2 PPL	2.36e-05	5	54	2	19029034
Pubmed	Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly.	CEP131 CEP152 KIF7	2.87e-05	38	54	3	36674791
Pubmed	Conserved motif of CDK5RAP2 mediates its localization to centrosomes and the Golgi complex.	AKAP9 PCNT	3.54e-05	6	54	2	20466722
Pubmed	Ccdc13 is a novel human centriolar satellite protein required for ciliogenesis and genome stability.	CEP131 PCNT	3.54e-05	6	54	2	24816561
Pubmed	Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis.	AKAP9 PCNT	3.54e-05	6	54	2	16198290
Pubmed	The Plk1 target Kizuna stabilizes mitotic centrosomes to ensure spindle bipolarity.	AKAP9 PCNT	3.54e-05	6	54	2	16980960
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	GRIPAP1 CCDC18 CEP131 CEP152 KIF7	4.46e-05	251	54	5	29778605
Pubmed	Human transcription factor protein interaction networks.	CCDC8 NUMA1 CEP131 CEP152 SRCAP TAF1L ZMYM4 KIF7 FBXW7 WDR48	6.10e-05	1429	54	10	35140242
Pubmed	The centrosomal protein pericentrin identified at the basal body complex of the connecting cilium in mouse photoreceptors.	AKAP9 PCNT	6.59e-05	8	54	2	22031837
Pubmed	CP110 cooperates with two calcium-binding proteins to regulate cytokinesis and genome stability.	AKAP9 PCNT	6.59e-05	8	54	2	16760425
Pubmed	NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.	KIR2DS3 KIR2DS5	6.59e-05	8	54	2	18681957
Pubmed	Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.	KIR2DS3 KIR2DS5	8.46e-05	9	54	2	7749980
Pubmed	Alternatively spliced forms of human killer inhibitory receptors.	KIR2DS3 KIR2DS5	8.46e-05	9	54	2	8662091
Pubmed	A mutation in the pericentrin gene causes abnormal interneuron migration to the olfactory bulb in mice.	NES AKAP9 PCNT	9.25e-05	56	54	3	20096683
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	CCDC8 FAT2 AKAP9 SYNE1	9.36e-05	152	54	4	34299191
Pubmed	Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.	KIR2DS3 KIR2DS5	1.06e-04	10	54	2	21206914
Pubmed	Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.	KIR2DS3 KIR2DS5	1.06e-04	10	54	2	12559621
Pubmed	Cell polarity and spindle orientation in the distal epithelium of embryonic lung.	NUMA1 PCNT	1.06e-04	10	54	2	21246661
Pubmed	Natural killer cells and immune surveillance.	KIR2DS3 KIR2DS5	1.29e-04	11	54	2	18830515
Pubmed	The adenomatous polyposis coli protein is an essential regulator of radial glial polarity and construction of the cerebral cortex.	NES PCNT	1.29e-04	11	54	2	19146812
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DS3 KIR2DS5	1.29e-04	11	54	2	19664392
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DS3 KIR2DS5	1.55e-04	12	54	2	20371502
Pubmed	The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults.	SERPINA3 ACE	1.55e-04	12	54	2	19008959
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR2DS3 KIR2DS5	1.55e-04	12	54	2	19181658
Pubmed	Novel embryonic neuronal migration and proliferation defects in Dcx mutant mice are exacerbated by Lis1 reduction.	NES PCNT	1.55e-04	12	54	2	20181597
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	KIR2DS3 KIR2DS5	1.55e-04	12	54	2	20137308
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR2DS3 KIR2DS5	1.55e-04	12	54	2	19936734
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	GRIPAP1 AKAP9 CEP250 CEP131 ZNF598 TBL3 PCNT	1.60e-04	754	54	7	33060197
Pubmed	CHIP as a membrane-shuttling proteostasis sensor.	SERPINA3 AKAP9 SRCAP	1.65e-04	68	54	3	29091030
Pubmed	Centriolar satellites assemble centrosomal microcephaly proteins to recruit CDK2 and promote centriole duplication.	CEP131 CEP152	1.83e-04	13	54	2	26297806
Pubmed	[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].	KIR2DS3 KIR2DS5	1.83e-04	13	54	2	18687225
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	KIR2DS3 KIR2DS5	1.83e-04	13	54	2	19934297
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	KIR2DS3 KIR2DS5	1.83e-04	13	54	2	19120281
Pubmed	Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.	CEP250 BYSL CEP152 TBL3 PCNT	1.85e-04	340	54	5	29478914
Pubmed	Mouse B-type lamins are required for proper organogenesis but not by embryonic stem cells.	NES PCNT	2.13e-04	14	54	2	22116031
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DS3 KIR2DS5	2.13e-04	14	54	2	19875891
Pubmed	Multiple sclerosis associates with LILRA3 deletion in Spanish patients.	KIR2DS3 KIR2DS5	2.13e-04	14	54	2	19421224
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DS3 KIR2DS5	2.13e-04	14	54	2	15896204
Pubmed	SUN1/2 and Syne/Nesprin-1/2 complexes connect centrosome to the nucleus during neurogenesis and neuronal migration in mice.	NES SYNE1	2.13e-04	14	54	2	19874786
Pubmed	CEP44 ensures the formation of bona fide centriole wall, a requirement for the centriole-to-centrosome conversion.	CEP152 PCNT	2.13e-04	14	54	2	32060285
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DS3 KIR2DS5	2.45e-04	15	54	2	20082646
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DS3 KIR2DS5	2.45e-04	15	54	2	19926642
Pubmed	Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.	KIR2DS3 KIR2DS5	2.45e-04	15	54	2	19850842
Pubmed	Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.	KIR2DS3 KIR2DS5	2.45e-04	15	54	2	20207982
Pubmed	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	KIR2DS3 KIR2DS5	2.45e-04	15	54	2	19493232
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DS3 KIR2DS5	2.45e-04	15	54	2	20356536
Pubmed	N-cadherin regulates signaling mechanisms required for lens fiber cell elongation and lens morphogenesis.	MYLK BFSP2	2.45e-04	15	54	2	28552735
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DS3 KIR2DS5	2.45e-04	15	54	2	20643584
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DS3 KIR2DS5	2.45e-04	15	54	2	17498266
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DS3 KIR2DS5	2.45e-04	15	54	2	19326408
Pubmed	The COPD genetic association compendium: a comprehensive online database of COPD genetic associations.	SERPINA3 ACE	2.80e-04	16	54	2	19933216
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DS3 KIR2DS5	2.80e-04	16	54	2	19897003
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DS3 KIR2DS5	2.80e-04	16	54	2	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DS3 KIR2DS5	2.80e-04	16	54	2	20670355
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DS3 KIR2DS5	2.80e-04	16	54	2	19527230
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DS3 KIR2DS5	2.80e-04	16	54	2	20652381
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DS3 KIR2DS5	2.80e-04	16	54	2	18668235
Pubmed	Strabismus regulates asymmetric cell divisions and cell fate determination in the mouse brain.	NES NUMA1	2.80e-04	16	54	2	19332887
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DS3 KIR2DS5	2.80e-04	16	54	2	19279038
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DS3 KIR2DS5	2.80e-04	16	54	2	17868255
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DS3 KIR2DS5	2.80e-04	16	54	2	18643961
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DS3 KIR2DS5	2.80e-04	16	54	2	19309280
Pubmed	Loss of cell polarity causes severe brain dysplasia in Lgl1 knockout mice.	NES PCNT	2.80e-04	16	54	2	15037549
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	KIR2DS3 KIR2DS5	2.80e-04	16	54	2	20331834
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DS3 KIR2DS5	2.80e-04	16	54	2	16403292
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR2DS3 KIR2DS5	2.80e-04	16	54	2	20210919
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	BDP1 GRIPAP1 CEP131 SRCAP ZMYM4 PCNT	2.95e-04	588	54	6	38580884
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	KIR2DS3 KIR2DS5	3.17e-04	17	54	2	19032228
Pubmed	The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.	KIR2DS3 KIR2DS5	3.17e-04	17	54	2	20173784
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	KIR2DS3 KIR2DS5	3.17e-04	17	54	2	20173792
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	KIR2DS3 KIR2DS5	3.17e-04	17	54	2	20483367
Interaction	CEP135 interactions	AKAP9 CEP95 CEP250 CGN CCDC18 CEP131 CEP152 ZMYM4 KIF7 PCNT	2.41e-09	272	54	10	int:CEP135
Interaction	SASS6 interactions	CEP250 CGN CCDC18 CEP131 CEP152 KIF7 PCNT FBXW7	9.62e-09	159	54	8	int:SASS6
Interaction	KRT8 interactions	NES GRIPAP1 AKAP9 USP32 CCDC18 BYSL CEP131 CEP152 PPL KIF7 PCNT	2.00e-08	441	54	11	int:KRT8
Interaction	WHAMMP3 interactions	AKAP9 CEP95 SYNE1 CEP250 CEP131 CEP152 PCNT	2.95e-08	119	54	7	int:WHAMMP3
Interaction	CEP63 interactions	SYNE1 CCDC18 CEP131 CEP152 BFSP2 KIF7 PCNT	4.83e-07	179	54	7	int:CEP63
Interaction	STIL interactions	AKAP9 CGN CCDC18 CEP131 CEP152 KIF7 PCNT	7.22e-07	190	54	7	int:STIL
Interaction	NDC80 interactions	AKAP9 CEP95 CEP250 CCDC18 CEP131 CEP152 KIF7 PCNT	1.69e-06	312	54	8	int:NDC80
Interaction	AMOT interactions	CCDC8 CEP250 CGN CCDC18 CEP131 CEP152 KIF7 PCNT	1.69e-06	312	54	8	int:AMOT
Interaction	PCM1 interactions	CCDC8 AKAP9 CEP95 CEP250 CCDC18 CEP131 CEP152 KIF7 PCNT	2.07e-06	434	54	9	int:PCM1
Interaction	TPTE2 interactions	AKAP9 CCDC18 CEP131 KIF7 PCNT	3.00e-06	84	54	5	int:TPTE2
Interaction	PLK4 interactions	CEP250 CGN CEP131 CEP152 ACE PCNT	3.45e-06	154	54	6	int:PLK4
Interaction	PCNT interactions	CCDC8 AKAP9 SYNE1 CCDC18 CEP131 CEP152 PCNT	3.52e-06	241	54	7	int:PCNT
Interaction	OBSL1 interactions	NES MISP CCDC8 ANKRA2 SYNE1 ECM2 CGN NUMA1 BYSL SRCAP TBL3 PCNT	3.62e-06	902	54	12	int:OBSL1
Interaction	TMOD1 interactions	CCDC18 LSP1 CEP131 CEP152 PCNT FBXW7	4.45e-06	161	54	6	int:TMOD1
Interaction	CCDC183 interactions	GRIPAP1 CEP131 BFSP2 PCNT	5.77e-06	44	54	4	int:CCDC183
Interaction	FAM167A interactions	NES CEP250 CCDC18 PPL FBXW7	5.81e-06	96	54	5	int:FAM167A
Interaction	KRT19 interactions	AKAP9 USP32 CCDC18 CEP131 CEP152 KIF7 PCNT	9.84e-06	282	54	7	int:KRT19
Interaction	BFSP1 interactions	CCDC18 BYSL BFSP2 PPL	1.13e-05	52	54	4	int:BFSP1
Interaction	KRT18 interactions	NES CCDC8 USP32 CCDC18 CEP131 CEP152 KIF7 PCNT	1.47e-05	419	54	8	int:KRT18
Interaction	DVL2 interactions	CCDC8 FAT2 AKAP9 SYNE1 USP32 NUMA1 BYSL ZNF598 WDR48	1.55e-05	557	54	9	int:DVL2
Interaction	USO1 interactions	GRIPAP1 AKAP9 DNAH2 BYSL ZNF488 PCNT	2.32e-05	215	54	6	int:USO1
Interaction	CCDC14 interactions	CCDC18 CEP131 CEP152 KIF7 PCNT	2.45e-05	129	54	5	int:CCDC14
Interaction	NINL interactions	CEP95 CEP250 CEP131 CEP152 ZNF598 ACE KIF7 PCNT	2.78e-05	458	54	8	int:NINL
Interaction	CCDC18 interactions	CEP250 CCDC18 KIF7 PCNT	3.30e-05	68	54	4	int:CCDC18
Interaction	MAPRE3 interactions	DCDC2 AKAP9 CEP131 ZNF598 KIF7 PCNT	3.38e-05	230	54	6	int:MAPRE3
Interaction	FAM184A interactions	CCDC18 CEP131 KIF7 PCNT	4.14e-05	72	54	4	int:FAM184A
Interaction	SEPTIN10 interactions	AKAP9 CEP131 CEP152 KIF7 PCNT	4.15e-05	144	54	5	int:SEPTIN10
Interaction	SDR42E2 interactions	MYLK NUMA1	4.21e-05	4	54	2	int:SDR42E2
Interaction	NIN interactions	CEP95 CEP250 CEP131 CEP152 ZNF598 KIF7 PCNT	4.63e-05	359	54	7	int:NIN
Interaction	PNMA2 interactions	MISP CCDC8 BYSL CEP131 KIF7 WDR48	5.51e-05	251	54	6	int:PNMA2
Interaction	AP2B1 interactions	AKAP9 CCDC18 CEP131 CEP152 WNK3 PCNT FBXW7	5.89e-05	373	54	7	int:AP2B1
Interaction	NDEL1 interactions	GRIPAP1 AKAP9 SYNE1 CCDC18 CEP152	7.69e-05	164	54	5	int:NDEL1
Interaction	KRT23 interactions	NES GRIPAP1 CEP250	7.75e-05	31	54	3	int:KRT23
Interaction	CEP290 interactions	CCDC8 CCDC18 CEP131 KIF7 PCNT	1.16e-04	179	54	5	int:CEP290
Interaction	SSX2IP interactions	CEP250 NUMA1 BYSL CEP131 KIF7 PCNT	1.17e-04	288	54	6	int:SSX2IP
Interaction	YWHAH interactions	NES CCDC8 AKAP9 CEP95 CGN CCDC18 CEP131 CEP152 WNK3 KIF7 PCNT	1.36e-04	1102	54	11	int:YWHAH
Interaction	DISC1 interactions	GRIPAP1 AKAP9 SYNE1 BFSP2 KIF7 PCNT FBXW7	1.41e-04	429	54	7	int:DISC1
Interaction	CDK5RAP2 interactions	AKAP9 CCDC18 CEP131 CEP152 PCNT	1.54e-04	190	54	5	int:CDK5RAP2
Interaction	SPICE1 interactions	CEP95 CEP250 CEP131 KIF7 PCNT	1.57e-04	191	54	5	int:SPICE1
Interaction	LATS1 interactions	AKAP9 CGN CCDC18 CEP131 CEP152 KIF7 PCNT	1.65e-04	440	54	7	int:LATS1
Interaction	RPAP1 interactions	CCDC8 POLR2D NUMA1 FBXW7	1.80e-04	105	54	4	int:RPAP1
Interaction	RALBP1 interactions	NES CEP250 WNK3 PPL KIF7	1.86e-04	198	54	5	int:RALBP1
Interaction	MED4 interactions	POLR2D CCDC18 CEP131 CEP152 KIF7 PCNT FBXW7	1.89e-04	450	54	7	int:MED4
Interaction	CEP131 interactions	CCDC8 CEP131 CEP152 KIF7 PCNT	1.95e-04	200	54	5	int:CEP131
Interaction	PXN interactions	AKAP9 CCDC18 CEP131 CEP152 KIF7 PCNT	2.62e-04	334	54	6	int:PXN
Interaction	FTL interactions	DCDC2 CEP95 CEP250 POLR2D SRCAP PCNT	3.26e-04	348	54	6	int:FTL
Interaction	CCDC8 interactions	CCDC8 ANKRA2 CEP250 CGN NUMA1 CEP131 KIF7 PCNT	3.35e-04	656	54	8	int:CCDC8
Interaction	DCTN2 interactions	AKAP9 POLR2D CEP131 CEP152 ZNF598 PCNT	3.68e-04	356	54	6	int:DCTN2
Interaction	SYCE1 interactions	AKAP9 CCDC18 CEP152 BFSP2	3.73e-04	127	54	4	int:SYCE1
Interaction	ANAPC2 interactions	CCDC18 CEP131 CEP152 KIF7 PCNT	4.02e-04	234	54	5	int:ANAPC2
Interaction	DYNLL1 interactions	AKAP9 NUMA1 CCDC18 CEP131 CEP152 ZMYM4 PCNT	4.04e-04	510	54	7	int:DYNLL1
Interaction	YWHAE interactions	CCDC8 AKAP9 CEP95 CEP250 POLR2D CGN CCDC18 CEP131 ZNF598 FBXW7 WDR48	4.22e-04	1256	54	11	int:YWHAE
Interaction	MAPRE1 interactions	MISP AKAP9 CEP250 NUMA1 CEP131 ZNF598 PCNT	4.23e-04	514	54	7	int:MAPRE1
Interaction	EBF2 interactions	NES SERPINA3 PPL	5.32e-04	59	54	3	int:EBF2
Interaction	PHLDB2 interactions	CCDC8 CEP250 CGN KIF7	5.84e-04	143	54	4	int:PHLDB2
Interaction	DCPS interactions	CEP250 BYSL CEP152 TBL3 PCNT FBXW7	6.29e-04	394	54	6	int:DCPS
Interaction	KIF7 interactions	CCDC8 CCDC18 CEP131 KIF7	6.31e-04	146	54	4	int:KIF7
Interaction	DYRK1A interactions	BDP1 CCDC8 USP32 CEP131 PPL PCNT FBXW7	6.46e-04	552	54	7	int:DYRK1A
Interaction	CEP350 interactions	CCDC8 CEP250 CEP152 PCNT	6.81e-04	149	54	4	int:CEP350
Interaction	GIGYF2 interactions	CCDC8 CEP250 CGN ZNF598 FBXW7	6.84e-04	263	54	5	int:GIGYF2
Cytoband	17q23.3	CEP95 USP32 ACE	6.11e-06	30	54	3	17q23.3
Cytoband	Ensembl 112 genes in cytogenetic band chr17q23	CEP95 USP32 ACE	3.92e-04	120	54	3	chr17q23
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS3 KIR2DS5	5.46e-04	18	35	2	620
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	BDP1 CACNB2 ZNF182 AKAP9 CEP95 CEP250 NUMA1 ZMYM4 KIF7 FBXW7	1.38e-05	780	51	10	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNB2 FAT2 MYLK FGF18 KIF7	9.73e-07	153	52	5	1524557514668f515ac1bbe847611f564b265b42
ToppCell	E17.5-Mesenchymal-myocytic_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NES CACNB2 MYLK LSP1 FGF18	3.20e-06	195	52	5	01a750d660993017af00736215cbcff2de5909c1
ToppCell	droplet-Kidney-nan-24m-Myeloid-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLA2G7 DNAH2 LSP1 ACE	4.31e-05	167	52	4	2ee1660be117e20f24557522345572d11cbee813
ToppCell	TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium-7\|TCGA-Endometrium / Sample_Type by Project: Shred V9	CACNB2 KLHDC1 MYLK ECM2	4.42e-05	168	52	4	a97e8e07ba949b30805aeed5f60fa5e092b9d3d4
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_C\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NES FAT2 APOBR WNK3	4.62e-05	170	52	4	81341bf4fe090af70b2091b6b2579ed08d76e22d
ToppCell	TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium\|TCGA-Endometrium / Sample_Type by Project: Shred V9	CACNB2 KLHDC1 MYLK ECM2	4.62e-05	170	52	4	cdc19013da7c41d1ed8400a6a643e4c684ff9912
ToppCell	TCGA-Endometrium-Solid_Tissue_Normal\|TCGA-Endometrium / Sample_Type by Project: Shred V9	CACNB2 KLHDC1 MYLK ECM2	4.62e-05	170	52	4	0bde0a40440c7fdf7ba89cac8831d4014e7a4807
ToppCell	TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue\|TCGA-Endometrium / Sample_Type by Project: Shred V9	CACNB2 KLHDC1 MYLK ECM2	4.62e-05	170	52	4	516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK ABCB6 LSP1 KIF7	5.06e-05	174	52	4	c529f3674b784f872f4387ffdeb46aecb619976b
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT2 SLC24A2 ZNF598 PPL	5.06e-05	174	52	4	207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ECM2 LSP1 ACE FGF18	6.16e-05	183	52	4	5cfcd589a480e67654d3d94e71916f122150db10
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ECM2 LSP1 ACE FGF18	6.16e-05	183	52	4	c3ea8d3b916ffcaca3156e0d77a952724554c4ab
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ECM2 LSP1 ACE FGF18	6.16e-05	183	52	4	81003ddc24164959dd41bb12fcac72638789b8f2
ToppCell	3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NES RBM44 SYNE1 FGF18	6.42e-05	185	52	4	fa94c4a1660967f211ba095606cd0aa37d38e17a
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	CCDC18 CEP152 BFSP2 KIF7	6.42e-05	185	52	4	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 MYLK SYNE1 FGF18	6.42e-05	185	52	4	e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	CACNB2 MYLK LSP1 FGF18	6.56e-05	186	52	4	e044b3428b7eacfdc72d0f57cdabaa1de04c74cd
ToppCell	3'-Adult-Appendix-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NES RBM44 SYNE1 FGF18	6.69e-05	187	52	4	37d8ee5c8bd6324749e5a2adef1d0482c75da80c
ToppCell	3'-Adult-Appendix-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NES RBM44 SYNE1 FGF18	6.69e-05	187	52	4	ec98d5e480b08854dfd0ba6b1dc6610455f90640
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 MYLK SYNE1 FGF18	6.83e-05	188	52	4	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	Control-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	NES MYLK SYNE1 ACE	6.83e-05	188	52	4	88b3415e33db81726dd29c1f50c886e057af50a0
ToppCell	COPD-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	NES MYLK SYNE1 ACE	6.83e-05	188	52	4	1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AKAP9 LINC00471 CCDC18 CEP152	6.83e-05	188	52	4	0476d7ee3e0ce78c3c5b111e9ade01098f9ea7ec
ToppCell	facs-Kidney-nan-3m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC8 SLC24A2 ECM2 PPL	6.98e-05	189	52	4	a5306561026e4dfcc39beeb785e5108ac595d136
ToppCell	facs-Kidney-nan-3m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC8 SLC24A2 ECM2 PPL	6.98e-05	189	52	4	381058f55908f84375b54601d617389ef43ab855
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 MYLK SYNE1 FGF18	6.98e-05	189	52	4	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	facs-Kidney-nan-3m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC8 SLC24A2 ECM2 PPL	6.98e-05	189	52	4	302b950a6ad578f8aeff7ea6fd15fe631225287d
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 MYLK SYNE1 FGF18	7.27e-05	191	52	4	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	BDP1 DCDC2 AKAP9 ANKRA2	7.41e-05	192	52	4	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	11.5-Airway-Epithelial-Bud_tip_adjacent\|Airway / Age, Tissue, Lineage and Cell class	MISP DCDC2 CGN PPL	7.41e-05	192	52	4	fbb34a959b9bd9cb72a5195a07f4653a957e4ca8
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MISP DCDC2 CGN PPL	7.41e-05	192	52	4	b73f24d1c55dfef1eb01c26da117dbf637ea080a
ToppCell	E15.5-Mesenchymal-myocytic_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYLK SYNE1 LSP1 FGF18	7.56e-05	193	52	4	3316d6a39abb6a518d45b846254325fc7a8b2035
ToppCell	E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYLK SYNE1 LSP1 FGF18	7.56e-05	193	52	4	e787e618f6e8a1e22be366ce606bf78831b60a90
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	BDP1 DCDC2 AKAP9 ANKRA2	7.56e-05	193	52	4	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	IPF-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	NES MYLK SYNE1 ACE	7.72e-05	194	52	4	777ce41c3f22c591e2d81120f189b834e53ffb4b
ToppCell	PCW_13-14-Epithelial-Epithelial_airway\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MISP DCDC2 CGN PPL	7.72e-05	194	52	4	7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CEP95 CCDC18 CEP152 PCNT	7.72e-05	194	52	4	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES MYLK LSP1 FGF18	7.87e-05	195	52	4	b0d408f8bc1701a87596ed55efcd90749fee33e6
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CACNB2 MYLK FGF18 NSMCE4A	7.87e-05	195	52	4	4dba732c8d8ecf0ed9ece1814dc4060402199ed9
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MISP DCDC2 CGN PPL	7.87e-05	195	52	4	d67a2b489c29bfd575751c13d2a5b1efdec5240a
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES MYLK LSP1 FGF18	7.87e-05	195	52	4	2514c1f23424b5fc664d326d31ffd22bafe74ef8
ToppCell	E17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CACNB2 MYLK LSP1 FGF18	7.87e-05	195	52	4	1daddd801bd4596fffbdb822fc326d5127c96004
ToppCell	Fibroblast-B_(Myofibroblast)\|World / shred on cell class and cell subclass (v4)	NES MYLK LSP1 FGF18	7.87e-05	195	52	4	a8d6416518f226e1ec2d6bdc9d4b90cef5cb1365
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES MYLK LSP1 FGF18	7.87e-05	195	52	4	a486a7acea0e91048cc48afa0dbd3926d30bc217
ToppCell	COPD-Stromal-Myofibroblast\|COPD / Disease state, Lineage and Cell class	SERPINA3 CACNB2 MYLK ECM2	8.03e-05	196	52	4	af206bb5bbb8b604a6212acd79878bcc3d326cec
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES MYLK LSP1 FGF18	8.03e-05	196	52	4	e4d04e1f82779e8afd4e32bbe38d1d3f6f64ab50
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES MYLK LSP1 FGF18	8.03e-05	196	52	4	f0fd7db22985d2bc84dc8bcbdb2d552e280121dd
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SERPINA3 CACNB2 MYLK ECM2	8.03e-05	196	52	4	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	P07-Mesenchymal-myocytic_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NES MYLK LSP1 FGF18	8.19e-05	197	52	4	378299fe2ec6ed2fc858febb78ff1ac0898e457d
ToppCell	COPD-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	SERPINA3 CACNB2 MYLK ECM2	8.19e-05	197	52	4	d51f484b4e01ac64233950d0b97fa88825ea1dbb
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES MYLK LSP1 FGF18	8.19e-05	197	52	4	26475b9e4d6bfc0ae818dea13d139888ed7e92f1
ToppCell	P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NES MYLK LSP1 FGF18	8.19e-05	197	52	4	2cec938caf6ffd031cea37277071487e59b2c71c
ToppCell	P03-Mesenchymal-myocytic_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NES MYLK LSP1 FGF18	8.19e-05	197	52	4	079db904a08743b3c555cb7b3f5fb5c978dde25a
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES MYLK LSP1 FGF18	8.19e-05	197	52	4	9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES MYLK LSP1 FGF18	8.19e-05	197	52	4	090a251194da3e2806989d9a522588f83f52da7f
ToppCell	COPD-Stromal\|COPD / Disease state, Lineage and Cell class	SERPINA3 CACNB2 MYLK ECM2	8.19e-05	197	52	4	d5390d86acaa8c39f1da893e8d2271f9ed2951d7
ToppCell	P07-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NES MYLK LSP1 FGF18	8.19e-05	197	52	4	b1135378d768fbbe62a75747d1e8653d35252187
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	BDP1 AKAP9 CCDC18 CEP152	8.19e-05	197	52	4	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES MYLK LSP1 FGF18	8.19e-05	197	52	4	43b5f8e917506c1717f9311584901b506ffd2c79
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES MYLK LSP1 FGF18	8.19e-05	197	52	4	155e63b33302a87393ace699b2f6d73abe9c5763
ToppCell	distal-3-mesenchymal-Fibromyocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CACNB2 MYLK ECM2 FGF18	8.35e-05	198	52	4	dc93886439a378a0c71e99acb8081bfb6b6d467b
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CACNB2 MYLK FGF18 NSMCE4A	8.35e-05	198	52	4	2d0c14f8cabab99bc6d7c27685437c78841c7245
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES MYLK LSP1 FGF18	8.35e-05	198	52	4	a4005a49cf6709b543994ceb51ecd5dc46197fa9
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SERPINA3 CACNB2 MYLK ECM2	8.35e-05	198	52	4	300d7cc56207d77168390fa1ffcbcf76767b1b80
ToppCell	distal-mesenchymal-Fibromyocyte-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CACNB2 MYLK ECM2 FGF18	8.35e-05	198	52	4	9d1d95e7703cfc70a8ad427e400c340dbd205db8
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNB2 MYLK SLC24A2 FGF18	8.35e-05	198	52	4	e9f434bfd072e590fe44d518057ee5aa653038f3
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MISP DCDC2 CGN PPL	8.35e-05	198	52	4	c477405b093f4e5374e57bcacf1fb204a0f7eb3b
ToppCell	PCW_10-12-Epithelial-Epithelial_airway\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MISP DCDC2 CGN PPL	8.35e-05	198	52	4	9a12e5e47236433e512c668005fe3f8be6fde95c
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 MYLK SLC24A2 SYNE1	8.35e-05	198	52	4	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	distal-mesenchymal-Fibromyocyte\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CACNB2 MYLK ECM2 FGF18	8.35e-05	198	52	4	fbfac1d10e4224990a094cc84b74bbc206881423
ToppCell	wk_08-11-Epithelial-Airway_epithelial_progenitor\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	MISP DCDC2 CGN PPL	8.51e-05	199	52	4	af664e0d41a889a75dbf6cf0d50acd26f5ab3a3a
ToppCell	11.5-Airway-Mesenchymal-Airway_Smooth_Muscle\|Airway / Age, Tissue, Lineage and Cell class	NES MYLK SLC24A2 FGF18	8.51e-05	199	52	4	1a8c77d241bd817a195e1532fd25f51358cb1ff1
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NES MYLK SYNE1 ACE	8.68e-05	200	52	4	3767abc75176779198505ebc6967d55ce322d9fe
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FAT2 AKAP9 CGN PPL	8.68e-05	200	52	4	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FAT2 AKAP9 CGN PPL	8.68e-05	200	52	4	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Tmsb4x_(Tmsb4x)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ABCB6 ZNF488 BFSP2	1.39e-04	86	52	3	db67c05c876a5649371c0dc6c941cc371bc2feb8
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Tmsb4x_(Tmsb4x)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ABCB6 ZNF488 BFSP2	1.39e-04	86	52	3	2778446e035c5585bce28ed0ef93b87b6ad90c6e
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PLA2G7 MYLK FGF18	2.37e-04	103	52	3	780a94c27ac3eb138a9f284251ae094d3e97ce71
ToppCell	Myeloid-C_(Cd16+_Monocyte)\|World / shred on cell class and cell subclass (v4)	PLA2G7 LSP1 APOBR	4.19e-04	125	52	3	c73a77340e79f73fd1f900724e82a94d82e6b1bf
ToppCell	LPS-antiTNF-Unknown-Endothelial-Monocytes-Macrophages\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NES CCDC18 CEP152	6.07e-04	142	52	3	b66f9602dba30d1d4fbcc49ceb112eb5bd916ba1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LSP1 ACE APOBR	6.85e-04	148	52	3	12fa2c4922f03803006c606b1b16e79441e3bb13
ToppCell	PND01-Immune-Immune_Myeloid-Granulocytic\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLA2G7 SYNE1 APOBR	6.85e-04	148	52	3	74f1f9d1a53dc1a09cb6a504cbbdc7496c5b6879
ToppCell	PND01-03-samps-Myeloid-Granulocyte\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	PLA2G7 LSP1 APOBR	6.98e-04	149	52	3	7bdb396de8a1ef27ab0c2aaf1452576f4b0b5561
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	PLA2G7 ZNF182 FGF18	6.98e-04	149	52	3	a6c24d8f3b5f08587f0a12cd63d166b68ea000c7
ToppCell	PND01-03-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	PLA2G7 LSP1 APOBR	6.98e-04	149	52	3	50f53018e525b3d252caa8bed9e075b1bb1086dd
ToppCell	PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLA2G7 SYNE1 APOBR	6.98e-04	149	52	3	4de52569611e63a780cde9bd111d6d9c11a05a11
ToppCell	PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLA2G7 SYNE1 APOBR	6.98e-04	149	52	3	c957ac23ad6343eacce7e6be4a6d3ac043af4f86
ToppCell	droplet-Kidney-nan-24m-Lymphocytic-CD45____macrophage\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLA2G7 ACE APOBR	7.12e-04	150	52	3	34774b015adecc2be56a471fda8994e89a6ad93e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SERPINA3 DCDC2 FGF18	7.54e-04	153	52	3	79c4f4ccdc8249c8461075c73491bc3b2d13344a
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT1_Precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	MISP RBM44 CGN	7.69e-04	154	52	3	8a643d91896af9b630a715fb284c1523d01ad1a3
ToppCell	367C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	PLA2G7 FGF18 WNK3	7.98e-04	156	52	3	fc8b8aef29d6d1c0f0c1d08280d8aaff8d30535e
ToppCell	(6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)\|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	MYLK SYNE1 ACE	8.13e-04	157	52	3	84f629b7f589ca8a1abc220fa740c4a6fdc1b579
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-CLP\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LSP1 APOBR KIF7	8.13e-04	157	52	3	d12f343454202da86a06d0369f8ffe5662cd091b
ToppCell	facs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLA2G7 MISP SYNE1	8.13e-04	157	52	3	9d4308312301cb922f156a7b6aededc9e1c62807
ToppCell	Healthy/Control-Treg\|Healthy/Control / Disease group and Cell class	CGN BFSP2 PPL	8.43e-04	159	52	3	16a322760c99f3e2c3b73cbb399f77868951d3cb
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLA2G7 LSP1 APOBR	8.58e-04	160	52	3	741e3b3f4ec5c77752da54746451f332435226e3
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLA2G7 USP32 APOBR	8.74e-04	161	52	3	e227f7b711475624cf80e77f235b1783d88d57b4
ToppCell	droplet-Marrow-nan-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLA2G7 SYNE1 ACE	8.74e-04	161	52	3	3f3a2148c8d65e6a06f8d8116a3aa58dda17d618
ToppCell	Healthy/Control-Treg\|World / Disease group and Cell class	CGN BFSP2 PPL	8.74e-04	161	52	3	457297cda5c9cee3bcc069fdecbbe24def027e5f
ToppCell	facs-Pancreas-Exocrine-18m-Hematologic-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLA2G7 LSP1 APOBR	8.74e-04	161	52	3	16f77e7a5444d2f2b210362816cd7a07b9b42af6
Disease	Seckel syndrome 1	CEP152 PCNT	8.10e-06	3	49	2	C4551474
Disease	proteinuria (is_implicated_in)	PLA2G7 ACE	5.64e-05	7	49	2	DOID:576 (is_implicated_in)
Disease	Seckel syndrome	CEP152 PCNT	6.11e-04	22	49	2	C0265202
Disease	nephrosis (biomarker_via_orthology)	NES ACE	6.11e-04	22	49	2	DOID:2527 (biomarker_via_orthology)
Disease	coronary artery disease (is_implicated_in)	PLA2G7 MYLK ACE	6.21e-04	100	49	3	DOID:3393 (is_implicated_in)
Disease	Coronary heart disease	PLA2G7 ACE	7.28e-04	24	49	2	C0010068
Disease	congenital diaphragmatic hernia (biomarker_via_orthology)	ACE KIF7	7.28e-04	24	49	2	DOID:3827 (biomarker_via_orthology)
Disease	Brugada Syndrome (disorder)	CACNB2 AKAP9	7.28e-04	24	49	2	C1142166
Disease	Colorectal Carcinoma	CACNB2 AKAP9 SYNE1 ABCB6 ZMYM4 FBXW7	1.04e-03	702	49	6	C0009402
Disease	IgA glomerulonephritis (is_implicated_in)	PLA2G7 ACE	1.14e-03	30	49	2	DOID:2986 (is_implicated_in)
Disease	left ventricular mass index	CACNB2 LSP1	1.46e-03	34	49	2	EFO_0009290

Protein segments in the cluster

Peptide	Gene	Start	Entry
TERNENQEESSQEVH	BDP1	2186	A6H8Y1
EQAIDREHERDVFQQ	AKAP9	2071	Q99996
EEIHRIQEQNEQDYR	CEP152	966	O94986
HDTNITAENARRQEE	ACE	71	P12821
EENLTQENQDRGTHV	SERPINA3	31	P01011
LQVHEEDQDVERSQV	ABCB6	216	Q9NP58
ATRIEQENVINHTDE	ANKRA2	166	Q9H9E1
EIRAEAEQQQQERAH	BFSP2	376	Q13515
DRESHQENEDRNSEL	LINC00471	56	Q8N535
DVDREQDHNECNKQR	CACNB2	611	Q08289
ADAEQDNQRAHDVDV	RBM44	711	Q6ZP01
VQRDIVQETQREEDH	MISP	351	Q8IVT2
QHTEEAIRQQEVEQL	MYLK	881	Q15746
EQQDTHELAVEVRDN	FAT2	2031	Q9NYQ8
DHQRQDQLREKQEEE	PPL	1076	O60437
VAEENVDFRIHVENQ	FGF18	26	O76093
REEQHQQQIAFSELE	KIF7	1111	Q2M1P5
ENQSHETLERENQEC	NES	561	P48681
RTVNREDSDEQDHQE	KIR2DS3	286	Q14952
AEREHEREEFQQEIQ	PCNT	1486	O95613
QEEETHIRNEQVRQR	PLA2G7	211	Q13093
RTVNREDSDEQDHQE	KIR2DS5	286	Q14953
AEARHQQVQAQREIE	CCDC18	1151	Q5T9S5
AEQAQEHEVETRALQ	CEP250	1911	Q9BV73
RQQEEEHTARNGEVV	FBXW7	46	Q969H0
RSQEDDAHNVQAVID	CEP95	56	Q96GE4
AHQQQRQGREEEEDE	ECM2	261	O94769
CQHERDRQLQAQDEE	LSP1	36	P33241
AAANHREEQRVQKEE	KLHDC1	381	Q8N7A1
QDVRDQLEQAQEERD	GRIPAP1	566	Q4V328
SEVTDNQREEAVHDQ	CCDC8	401	Q9H0W5
EFEEDQREHRAAVQQ	DNAH2	776	Q9P225
VTEEEAERFIHQVNQ	CEP131	256	Q9UPN4
QARQQQEELEAEHGT	BYSL	61	Q13895
EQVEEILDHSEQQAR	DCDC2	386	Q9UHG0
TARQEQHEAQAQVAE	NUMA1	661	Q14980
LEHRKQQNESAEDEQ	POLR2D	41	O15514
REEITVQQVHEETAN	SYNE1	426	Q8NF91
VDENERQNGAANHVE	SLC24A2	396	Q9UI40
DINEVAEDESQRHQQ	TAF1L	111	Q8IZX4
EENEGFEHNTQVRNQ	NSMCE4A	336	Q9NXX6
EEQQEGNDAEAQRRE	SRCAP	306	Q6ZRS2
DRSGQAQERQESHEQ	APOBR	151	Q0VD83
AQERQESHEQEVNRE	APOBR	156	Q0VD83
EEVASRDQEVEHVRQ	CGN	506	Q9P2M7
RDQEVEHVRQQYQRD	CGN	511	Q9P2M7
AQREVEEQHEVNEQL	CGN	1131	Q9P2M7
RQVDAQAQEREHDDP	ZNF488	111	Q96MN9
VDEQIERQHQDDQDK	ZNF182	101	P17025
ENEVNHVNGEQENRV	WDR48	486	Q8TAF3
TEAEQAEEQARQEEQ	TBL3	636	Q12788
AEEEHRQQEAERQKS	ZC3H11B	411	A0A1B0GTU1
QQQEEARRSEDQEEG	ZNF598	356	Q86UK7
QNRQRRDRQTHEDEQ	RPTN	766	Q6XPR3
VDEHESVEQSRRAQA	USP32	1216	Q8NFA0
RVTQHESDNENEIQI	ZMYM4	116	Q5VZL5
AECEETEVDQHVRQQ	WNK3	536	Q9BYP7